These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21631422)

  • 21. Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection.
    Oerlemans MI; Koudstaal S; Chamuleau SA; de Kleijn DP; Doevendans PA; Sluijter JP
    Int J Cardiol; 2013 May; 165(3):410-22. PubMed ID: 22459400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide 1--a cardiologic dimension.
    Treiman M; Elvekjaer M; Engstrøm T; Jensen JS
    Trends Cardiovasc Med; 2010 Jan; 20(1):8-12. PubMed ID: 20685571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
    Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
    Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calpain and caspase-3 inhibitors reduce infarct size and post-ischemic apoptosis in rat heart without modifying contractile recovery.
    Perrin C; Ecarnot-Laubriet A; Vergely C; Rochette L
    Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL497-505. PubMed ID: 14995081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiomyocyte Ca2+ dynamics: clinical perspectives.
    Aronsen JM; Louch WE; Sjaastad I
    Scand Cardiovasc J; 2016; 50(2):65-77. PubMed ID: 26729487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of autophagy by Beclin 1 in the heart.
    Maejima Y; Isobe M; Sadoshima J
    J Mol Cell Cardiol; 2016 Jun; 95():19-25. PubMed ID: 26546165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion.
    Liu HR; Gao E; Hu A; Tao L; Qu Y; Most P; Koch WJ; Christopher TA; Lopez BL; Alnemri ES; Zervos AS; Ma XL
    Circulation; 2005 Jan; 111(1):90-6. PubMed ID: 15611365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sudden cardiac death and the role of medical therapy.
    Arshad A; Mandava A; Kamath G; Musat D
    Prog Cardiovasc Dis; 2008; 50(6):420-38. PubMed ID: 18474285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment with B-type natriuretic peptide protects the heart from ischemia-reperfusion injury by inhibiting myocardial apoptosis.
    Wu B; Jiang H; Lin R; Cui B; Wen H; Lu Z
    Tohoku J Exp Med; 2009 Oct; 219(2):107-14. PubMed ID: 19776527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress in clinical cardiology. The clinical cardiologist's response to new cardiovascular drugs].
    Borrás-Pérez X; Murga-Eizagaechevarría N
    Rev Esp Cardiol; 2011; 64 Suppl 1():73-80. PubMed ID: 21276493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.
    Ye L; Ni X; Zhao ZA; Lei W; Hu S
    J Cardiovasc Transl Res; 2018 Oct; 11(5):366-374. PubMed ID: 29845439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic therapy in patients with chronic heart failure and chronic kidney disease: a complex issue.
    Acquarone N; Castello C; Antonucci G; Lione S; Bellotti P
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):13-21. PubMed ID: 19708224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphological aspects of apoptosis in heart diseases.
    Takemura G; Fujiwara H
    J Cell Mol Med; 2006; 10(1):56-75. PubMed ID: 16563222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losing heart: the role of apoptosis in heart disease--a novel therapeutic target?
    Gill C; Mestril R; Samali A
    FASEB J; 2002 Feb; 16(2):135-46. PubMed ID: 11818361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of p38 kinase by DUSP4 is important in regulating cardiovascular function under oxidative stress.
    Barajas-Espinosa A; Basye A; Angelos MG; Chen CA
    Free Radic Biol Med; 2015 Dec; 89():170-81. PubMed ID: 26184564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Currying the heart: curcumin and cardioprotection.
    Srivastava G; Mehta JL
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):22-7. PubMed ID: 19153099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of extracellular signal-regulated kinases 1/2 provides neuroprotection in spinal cord ischemia/reperfusion injury in rats: relationship with the nuclear factor-kappaB-regulated anti-apoptotic mechanisms.
    Lu K; Liang CL; Liliang PC; Yang CH; Cho CL; Weng HC; Tsai YD; Wang KW; Chen HJ
    J Neurochem; 2010 Jul; 114(1):237-46. PubMed ID: 20403072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tournefolic acid B, derived from Clinopodium chinense (Benth.) Kuntze, protects against myocardial ischemia/reperfusion injury by inhibiting endoplasmic reticulum stress-regulated apoptosis via PI3K/AKT pathways.
    Yu Y; Xing N; Xu X; Zhu Y; Wang S; Sun G; Sun X
    Phytomedicine; 2019 Jan; 52():178-186. PubMed ID: 30599897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes.
    Engelbrecht AM; Niesler C; Page C; Lochner A
    Basic Res Cardiol; 2004 Sep; 99(5):338-50. PubMed ID: 15309413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.